Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Rosenberg, N K
Sorensen, S A
and
Christensen, A L
1995.
Neuropsychological characteristics of Huntington's disease carriers: a double blind study..
Journal of Medical Genetics,
Vol. 32,
Issue. 8,
p.
600.
Dihenia, Bhupesh H.
and
Green, Robert C.
1995.
Non-Alzheimer's degenerative dementias.
Current Opinion in Psychiatry,
Vol. 8,
Issue. 1,
p.
51.
Lovestone, S
Hodgson, S
Sham, P
Differ, A M
and
Levy, R
1996.
Familial psychiatric presentation of Huntington's disease..
Journal of Medical Genetics,
Vol. 33,
Issue. 2,
p.
128.
Ross, Christopher A.
Margolis, Russell L.
Rosenblatt, Adam
Ranen, Neal G.
Bêcher, Mark W.
and
Aylward, Elizabeth
1997.
Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA).
Medicine,
Vol. 76,
Issue. 5,
p.
305.
O'Shea, Brian
1997.
A review of Huntington's disease.
International Journal of Psychiatry in Clinical Practice,
Vol. 1,
Issue. 2,
p.
135.
1997.
Movement disorders and substance abuse.
Psychiatric Services,
Vol. 48,
Issue. 5,
p.
634.
Tsuang, Debby
DiGiacomo, Lilly
Lipe, Hillary
and
Bird, Thomas D.
1998.
Familial aggregation of schizophrenia-like symptoms in huntington's disease.
American Journal of Medical Genetics,
Vol. 81,
Issue. 4,
p.
323.
Anderson, Karen E.
and
Marder, Karen S.
2001.
An overview of psychiatric symptoms in Huntington’s disease.
Current Psychiatry Reports,
Vol. 3,
Issue. 5,
p.
379.
Castellon, Steven A.
Hinkin, Charles H.
and
Satz, Paul
2002.
Comprehensive Handbook of Psychopathology.
p.
813.
Rubinsztein, David C.
2003.
Genetics of Movement Disorders.
p.
365.
Bonelli, Raphael M
and
Hofmann, Peter
2004.
A review of the treatment options for Huntington’s disease.
Expert Opinion on Pharmacotherapy,
Vol. 5,
Issue. 4,
p.
767.
Davies, Robert D.
Thurstone, Christian
and
Woyewodzic, Kelly
2004.
Substance use disorders and neurologic illness.
Current Treatment Options in Neurology,
Vol. 6,
Issue. 5,
p.
421.
Anderson, Karen E.
2005.
Huntington's Disease and Related Disorders.
Psychiatric Clinics of North America,
Vol. 28,
Issue. 1,
p.
275.
Bonelli, Raphael M
and
Hofmann, Peter
2007.
A systematic review of the treatment studies in Huntington’s disease since 1990.
Expert Opinion on Pharmacotherapy,
Vol. 8,
Issue. 2,
p.
141.
van Duijn, E.
Kingma, E.M.
and
van der Mast, R.C.
2007.
Psychopathology in Verified Huntington’s Disease Gene Carriers.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 19,
Issue. 4,
p.
441.
Chou, Kelvin L
Borek, Leora L
and
Friedman, Joseph H
2007.
The management of psychosis in movement disorder patients.
Expert Opinion on Pharmacotherapy,
Vol. 8,
Issue. 7,
p.
935.
Gil, Joana M.
and
Rego, Ana Cristina
2008.
Mechanisms of neurodegeneration in Huntington’s disease.
European Journal of Neuroscience,
Vol. 27,
Issue. 11,
p.
2803.
Gil-Mohapel, Joana
Simpson, Jessica M.
Ghilan, Mohamed
and
Christie, Brian R.
2011.
Neurogenesis in Huntington's disease: Can studying adult neurogenesis lead to the development of new therapeutic strategies?.
Brain Research,
Vol. 1406,
Issue. ,
p.
84.
Bonelli, Raphael M.
and
Beal, M. Flint
2012.
Neurobiology of Psychiatric Disorders.
Vol. 106,
Issue. ,
p.
507.
Hult Lundh, Sofia
Nilsson, Nathalie
Soylu, Rana
Kirik, Deniz
and
Petersén, Åsa
2013.
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
Human Molecular Genetics,
Vol. 22,
Issue. 17,
p.
3485.
eLetters
No eLetters have been published for this article.